Chronic and non-canonical cGAS-STING activation: implications for health, disease, cancer, and emerging therapeutic...

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is a key component of the innate immune system, traditionally associated with antiviral responses.
• Dysregulated or chronic activation of this pathway is increasingly linked to various human pathological conditions, including cancer.
• While STING agonists are explored for cancer immunotherapy, the pathway's role extends beyond its canonical function.

Purpose of the Study:

• To discuss the diverse pathways regulating cGAS-STING activation, focusing on chronic and non-canonical mechanisms.
• To explore the association of these aberrant cGAS-STING pathway activations with human diseases and cancer survival.
• To review potential therapeutic opportunities arising from a deeper understanding of the cGAS-STING pathway.

Main Methods:

• Literature review and synthesis of current research on cGAS-STING pathway activation.
• Analysis of canonical, chronic, and non-canonical signaling mechanisms.
• Discussion of disease associations and therapeutic strategies.

Main Results:

• The cGAS-STING pathway can be activated through chronic and non-canonical routes, deviating from its classical antiviral role.
• These alternative activation modes are associated with various human diseases and influence cancer survival.
• Novel therapeutic avenues targeting the cGAS-STING pathway in cancer are being developed.

Conclusions:

• The cGAS-STING pathway's involvement in disease and cancer is complex, involving both canonical and non-canonical activation.
• Targeting chronic and non-canonical cGAS-STING signaling presents promising therapeutic strategies for cancer treatment.
• Further research into these pathways is essential for developing effective immunotherapies.